Reduction of Serum Prostate-Specific Antigen Levels following Varicella-Zoster Infection and Valaciclovir Treatment in Prostate Cancer

RR (Roy) Jurhill, H de Veen, Arno van Leenders, Paul Verhagen

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)


We present two prostate cancer patients, including one with a castration-resistant cancer whose rising serum prostate-specific antigen (PSA) levels showed a remarkable drop after a reactivated varicella-zoster virus infection treated with valaciclovir. In one patient, we found a temporary decrease in serum PSA lasting for at least 4 mo. In the patient with castration-resistant prostate cancer, serum PSA decreased to <0.01 mu g/l and has remained undetectable since. (C) European Association of Urology Published by Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)392-394
Number of pages3
JournalEuropean Urology
Issue number2
Publication statusPublished - 2009

Cite this